How will the system adapt to ongoing technological changes as well as work to shape them?
The BioSense 2.0 development team is currently focused on establishing data feeds from current participants to the new environment, and ensuring that jurisdictions using BioSense 2.0 as a Meaningful Use “catcher’s mitt” will be able to receive data elements, outlined in the ISDS Recommendation for Core Processes and EHR Requirements for Public Health Syndromic Surveillance. Our design and development team will continue upgrading and enhancing the application throughout the life of the project. Our intent is to continue working with end-users to update the system to reflect new potential uses, respond to user needs as they emerge, and adapt to an evolving technical landscape, going forward.
Have the cost estimates of the cloud assumed space and processing time only for the current rendition of the BioSense 2.0? If we're able to get a more robust system in the cloud, will the costs become prohibitive?
The current cloud cost estimates are designed with significant room for expansion beyond the initial implementation of BioSense 2.0. The cloud hosting solution will offer cost-effective infrastructure that will support very high user adoption and heavy traffic for the BioSense 2.0 system.
The BioSense 2.0 Governance is working the community to discuss the details of adding additional functionality and features/tools in the cloud environment. Additional details regarding the service and resource requirements will be shared as they become available.
We have too many passwords to remember for multiple surveillance systems. Can the new system be a dashboard that will include multiple surveillance systems so that we only need one password?
Our development team is evaluating the integration of other surveillance analysis systems to determine the suitability and compatibility within the new BioSense environment. We hope to offer some streamlined access to other utilities for data analysis and visualization.
Will additional CDC surveillance systems be included in the new system, like notifiable disease reporting?
The BioSense 2.0 is designed to be extensible, to grow in order to incorporate additional data feeds that would support the requirements of the system beyond syndromic surveillance. We are currently focused on syndromic surveillance only. The Governance will continue to work with CDC and the BioSense 2.0 community to decide how to advance future iterations.
How will other data streams be handled, such as school absentee data, pharmacy data, foodborne outbreaks, census data, etc?
The BioSense 2.0 development team is focused first on establishing data feeds from current contributors to the new environment, and ensuring that new jurisdictions using BioSense 2.0 as a Meaningful Use “catcher’s mitt” will be able to receive data elements, outlined in the ISDS Recommendation for Core Processes and EHR Requirements for Public Health Syndromic Surveillance. The Governance and CDC can evaluate additional data feeds to integrate in future versions of the system as is necessary. If you have any specific suggestions, please submit your feedback to email@example.com.